Press Releases | Longboard Pharmaceuticals

Skip to main navigation

Corporate Menu

About
Our Approach
Patients
Investors
Longboard Life
- Overview
- Culture and Benefits
Contact

Press Releases

Year

June 3, 2024

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

May 6, 2024

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

May 2, 2024

Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates

April 3, 2024

Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15

April 2, 2024

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

March 12, 2024

Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates

March 1, 2024

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

February 2, 2024

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

February 1, 2024

Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February

January 8, 2024

Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Next page
Last page

Displaying 11 - 20 of 24

©2024 Longboard Pharmaceuticals Privacy Policy | Terms of Use

Corporate Menu

About
Our Approach
Patients
Investors
Longboard Life
- Overview
- Culture and Benefits
Contact